Clinical Trials Logo

Puerperal Disorder clinical trials

View clinical trials related to Puerperal Disorder.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04222348 Active, not recruiting - Clinical trials for Diabetes, Gestational

MeDiGes Study: Metformine Use in Gestational Diabetes

FIMMET201501
Start date: October 26, 2016
Phase: Phase 3
Study type: Interventional

Women with gestational diabete (GD) who do not meet glycemic control objectives with diet will be assigned to two treatment groups randomly. One: metformin at a dose of 850-2550mg every 24h; two: insulin detemir associated or not with rapid insulin analogue (aspart) according to your glycemic controls. The Metformin group may additionally receive insulin in a second time in case the glycemic control is not appropriate with monotherapy.